Sickle cell disease: Ischemia and seizures

Annals of Neurology

Volumn 58, Issue 2, 2005, Pages 290-302

  Prengler, Mara ^a,d   Pavlakis, Steven G ^b   Boyd, Stewart ^a,c   Connelly, Alan ^a   Calamante, Fernando ^a   Chong, W K ^a,c   Saunders, Dawn ^c   Cox, Timothy ^c   Bynevelt, Michael ^c   Lane, Roderick ^c   Laverty, Aidan ^c   Kirkham, Fenella J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MAIMONIDES MEDICAL CENTER   (United States)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d Wolfson Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; BRAIN ISCHEMIA; BRAIN PERFUSION; CHILD; DIFFUSION WEIGHTED IMAGING; DOPPLER ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; FEMALE; HEADACHE; HUMAN; LEARNING DISORDER; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; SEIZURE; SICKLE CELL ANEMIA; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CEREBRAL INFARCTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ELECTROENCEPHALOGRAPHY; FEMALE; FUNCTIONAL LATERALITY; HISTORY, ANCIENT; HUMANS; INFANT; ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; SEIZURES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 23244454435     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20556     Document Type: Article

References (43)

1. Liu JE, Gzesh DJ, Ballas SK. The spectrum of epilepsy in sickle cell anemia. J Neurol Sci 1994;123:6-10.
2. Adams RJ. Neurological complications. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:599-621.
3. Kinney TR, Sleeper LA, Wang WC, et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 1999;103: 640-645.
4. Danesi MA. Acquired aetiological factors in Nigerian epileptics (an investigation of 378 patients). Trop Geogr Med 1983;35: 293-297.
5. Henderson JN, Noetzel MJ, McKinstry RC, et al. Reversible posterior leukencephalopathy syndrome and silent cerebral infarcts are associated with acute chest syndrome in sickle cell disease. Blood 2003;101:415-419.
6. Coley SC, Porter DA, Calamante F, et al. Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. Am J Neuroradiol 1999;20:1507-1510.
7. Horton DP, Ferriero DM, Mentzer WC. Nontraumatic fat embolism syndrome in sickle cell anemia. Pediatr Neurol 1995;12: 77-80.
8. Hamdan JM, Mallouh AA, Ahmad MS. Hypertension and convulsions complicating sickle cell anaemia: possible role of transfusion. Ann Trop Paediatr 1984;4:41-43.
9. Wierenga KJ, Serjeant BE, Serjeant GR. Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. J Pediatr 2001;139:438-442.
10. Nadvi SZ, Sarnaik S, Ravindranath Y. Low frequency of meperidine-associated seizures in sickle cell disease. Clin Pediatr (Phila) 1999;38:459-462.
11. Zolezzi M, Al-Mohaimeed SA. Seizures with intravenous codeine phosphate. Ann Pharmacother 2001;35:1211-1213.
12. Royal JE, Seeler RA. Hypertension, convulsions, and cerebral haemorrhage in sickle-cell anemia patients after blood-transfusions. Lancet 1978;2:1207.
13. Siegel JF, Rich MA, Brock WA. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome. J Urol 1993;150:1480-1482.
14. Abboud MR, Jackson SM, Barredo J, et al. Neurological complications following bone marrow transplantation for sickle cell disease. Bone Marrow Transplant 1996;17:405-407.
15. Huttenlocher PR, Moohr JW, Johns L, Brown FD. Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics 1984;73:615-621.
16. van Mierlo TD, van den Berg HM, Nievelstein RAJ, Braun KPJ. An unconscious girl with sickle cell disease. Lancet 2003; 361:136.
17. Kirkham FJ, Calamante F, Bynevelt M, et al. Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Ann Neurol 2001;49:477-485.
18. Adams RJ, Nichols FT, Figueroa R, et al. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 1992;23:1073-1077.
19. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997;42:699-704.
20. Kirkham FJ, Hewes DKM, Prengler M, et al. Nocturnal hypoxemia predicts central nervous system events in sickle cell disease. Lancet 2001;357:1656-1659.
21. Zafeiriou DI, Prengler M, Gombakis N, et al. Central nervous system abnormalities in young patients with Sβ thalassemia. Ann Neurol 2004;55:835-839.
22. Moran CJ, Siegel MJ, DeBaun MR. Sickle cell disease: imaging of cerebrovascular complications. Radiology 1998;206: 311-321.
23. Calamante F, Porter DA, Gadian DG, Connelly A. Correction for eddy current induced Bo shifts in diffusion-weighted echoplanar imaging. Magnetic Reson Med 1999;41:95-102.
24. Ulug AM, Beauchamp NJ, Bryan RN, van Zijil PC. Absolute quantitation of diffusion constants in human stroke. Stroke 1997;28:483-490.
25. Ostergaard L, Weisskoff RM, Chester DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
26. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000;44: 466-473.
27. Prengler M, Pavlakis SG, Prohovnik I, Adams RJ. Sickle cell disease: the neurological complications. Ann Neurol 2002;51: 543-552.
28. Adamolekum B, Durosinmi MA, Olowu W, Adediran I. The prevalence and classification of epileptic seizures in Nigerians with sickle-cell anaemia. J Trop Med Hyg 1993;96:288-290.
29. Cleary P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet 2004;363:1184-1186.
30. Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease. Neurology 1998;51:169-176.
31. Wang WC, Langston JW, Steen RG, et al. Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr 1998;132:994-998.
32. Abboud MR, Cure J, Granger S, et al. STOP study. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood 2004;103:2822-2826.
33. Reed W, Jagust W, Al-Mateen M, Vichinsky E. Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol 1999;60:268-272.
34. Powars DR, Conti PS, Wong W-Y, et al. Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood 1999;93:71-79.
35. Rodgers GP, Clark CM, Larson SM, et al. Brain glucose metabolism in neurologically normal patients with sickle cell disease. Arch Neurol 1988;45:78-82.
36. Herold S, Brozovic M, Gibbs J, et al. Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography. Stroke 1986;17:692-698.
37. Theodore WH, Kelley K, Toczek MT, Gaillard WD. Epilepsy duration, febrile seizures, and cerebral glucose metabolism. Epilepsia 2004;45:276-279.
38. Aylett SE, Neville BGR, Cross JH, et al. Sturge-Weber syndrome: cerebral haemodynamics during seizure activity. Dev Med Child Neurol 1999;41:480-485.
39. Topolnik L, Steriade M, Timofeev I. Partial cortical deafferentation promotes development of paroxysmal activity. Cereb Cortex 2003;13:883-893.
40. Prohovnik I, Pavlakis SG, Piomelli S, et al. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology 1989; 39:344-348.
41. Calabresi P, Cupini LM, Centonze D, et al. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol 2003;53:693-702.
42. Oguz KK, Golay X, Pizzini FB, et al. Sickle cell disease: continuous arterial spin-labeling perfusion MR imaging in children. Radiology 2003;227:567-574.
43. Wolf RL, Alsop DC, Levy-Reis I, et al. Detection of mesial temporal lobe hypoperfusion in patients with temporal lobe epilepsy by use of arterial spin labelled perfusion MR imaging. Am J Neuroradiol 2001;22:1334-1341.